Contexts are constantly changing in the pharmaceutical industry. Discovering, developing and introducing new therapies is now more complex and difficult than at any time in the past 50 years. Disruptive trends and technologies have increased the risks of innovation for health care players, from providers to manufacturers. Yet innovation remains the lifeblood of the health care industry – and it is not just innovation at the molecular level. Pharmaceutical firms are augmenting their drug discovery, development and marketing efforts with smart therapy adherence programs, generic drug manufacturing, in-licensing activities and enhanced sales force management. In fact, they are pursuing innovation through a variety of non-traditional routes. In this environment, it is more important than ever for business decisions to be informed by high-quality market intelligence.

A decade ago pharmaceutical and device companies focused most of their business intelligence efforts on understanding the needs of professional customers and influencers – doctors, technicians, nurses, and hospital administrators. But the advent of DTC advertising fueled the need for market intelligence from health care consumers. Knowledge Networks uses its unique assets and expertise advising consumer-facing firms to help pharmaceutical clients decode the 21st century health care consumer. This involves meshing the perspectives of consumers and suffering populations with those of other health care constituents such as:

• caregivers
• referring, prescribing and influencing physicians
• nurse practitioners and physician assistants
• managed care organizations
• patient advocacy groups

We bring these insights to life through a combination of creative analytics, fresh designs and challenging workshops that ensure the end result will be actionable and valuable.